tiprankstipranks
Trending News
More News >
Prelude Therapeutics (PRLD)
NASDAQ:PRLD
US Market

Prelude Therapeutics (PRLD) Revenue

Compare
168 Followers

Prelude Therapeutics Revenue

Prelude Therapeutics had a revenue of 6.50M in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 10.50M, Decreased 50.00%. In the fiscal year ending Dec 31, 2024, Prelude Therapeutics had annual revenue of 7.00M with Infinity% growth.
Revenue (ttm)
10.50M
Revenue Growth
250.00%
P/S Ratio
18.50
Revenue/Employee
$53,435
Employees
131
Market Cap
$129.47M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
7.00M-700,000,000.00%
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018